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patients, and found the tibial insertion size and intercondylar notch width is less than other pub-
lished in the West, besides the length and inclination angle of ACL. Our date also suggest that
MRI preoperative measurement can be confidently used in operative planning and our patients
could just perform SB ACL-R, and the intercondylar notch width has the correlation with the
weight and height.
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Introduction: A number of treatment procedures have been developed for chondral defects in
the knee joint. The authors previously reported the prospective multicenter clinical trial of atel-
locollagen-associated autologous chondrocyte implantation (ACI) for the repair of full-thick-
ness chondral defects of the knees. In this procedure, the clinical scores based on Lysholm
scale and knee-function scale improved significantly. Therefore, this atellocollagen-associated
ACI (JACC: Japan Tissue Engineering, Gamagori, Japan) is approved by the Japanese Health
Insurance since 2013. The purpose of this study was to evaluate short-term clinical outcome
and complication in patients undergoing atellocollagen-associated ACI for the repair of chon-
dral defects of the knees.
Methods: Between 2014 and 2015, we prospectively evaluated the clinical outcome and mag-
netic resonance imaging (MRI) of transplanting autologous chondrocytes cultured in atelocolla-
gen gel for the treatment of full-thickness defects of cartilage in five cases (five knees) with
cartilage lesions on a femoral condyle. There were 5 men with a mean age of 40 years (range:
30-47). The patients were included in this study if (1) they had at least one knee full-thickness
chondral lesion caused by trauma, or osteochondritis dissecans; (2) the chondral lesion had not
been improved or was not expected to be improved by conventional treatments including arthro-
scopy, debridement, marrow stimulation technique, or autologous osteochondral transplantation;
(3) the area of their chondral defect was 4 cm2. The causes of the osteochondral defect ware
trauma (four knees) and osteochondritis dissecans (one knee). Concerning previous surgical pro-
cedures, osteochondral autologous implantation in one knee with osteochondritis dissecans. The
lesions were on the medial femoral condyle in three knees and lateral femoral condyle in two
knees. All cases underwent atellocollagen-associated ACI combined with; reconstruction of
anterior cruciate ligament (ACL) in two knees, iliac bone graft in one knee, osteochondral autol-
ogous transplantation in one knee, reconstruction of lateral meniscus using semitendinous tendon
in one knee. In surgical procedure, the patients underwent a two-stage procedure that included
cartilage harvest and subsequent implantation of autologous chondrocytes embedded in atelocol-
lagen gel. The cartilage biopsy was sent to a single facility (Japan Tissue Engineering), where
chondrocytes were isolated from the cartilage biopsy, the engineered cartilage was prepared,
and the chondrocytes were cultured to expand the cell population. The tissue-engineered carti-
lage was implanted 28 days. A medial or lateral parapatellar arthrotomy was carried out under
tourniquet control. The chondral lesion was debrided as far as normal surrounding cartilage and
until subchondral bone was visible. The defect was covered by a sutured periosteal flap after har-
vest of the cartilage. The flap was shaped and sutured to the surrounding rim of normal cartilage.
After suturing half of the border of the flap, the chondrocyteeatelocollagen gel was placed in the
defect, and the remaining border of the flap was sutured. Two weeks after transplantation, con-
tinuous passive movement of the joint was begun. Partial weight bearing was introduced 3 weeks
after surgery and was gradually increased to full weight bearing with muscle training during the
first 6 weeks after surgery. We performed clinical and MRI examinations on these patients at
before surgery and the latest follow-up periods after surgery (mean 8.8 months, range: 3-13
months). We also performed arthroscopic biopsy in two knees.
Results: The mean size of chondral defect was 4.2 cm2 (range: 4-6 cm2). The Lysholm
score significantly improved from 73.5 points to 85.5 points. Regarding the Knee injury
and Osteoarthritis Outcome Score (KOOS), the total score significantly increased from 65
points to 81 points. In one case, the graft was detached at 8 months after the implantation,
and arthroscopic debridement was required. MRI evaluation demonstrated complete defect
coverage in 4 cases. Defect filling was defined as complete in 4 cases, and the remaining
1 case had near-complete defect filling. 4 cases had an intact interface of the repair tissue
and the adjacent femoral cartilage. A biopsy was performed at the site of chondral implan-
tation in two case, and we confirmed cartilage-like tissue with a proteoglycan-rich matrix
pathologically.
Discussion: This study demonstrated there was excellent short-term outcome of atellocollagen-
associated ACI. However, the treatment failures were subsequently treated with graft removal in
one patient, who had a marked hypertrophic response at the grafted site and then detachment of
approximately half of the graft. This case had been performed osteochondral autologous implan-
tation before atellocollagen-associated ACI, so the reason of detachment was thought to be
osteosclerosis of the subchondral bone for implantation. We need additional follow-up of the
cases in the present study.Conclusion: The findings of the present study suggest that transplanting chondrocytes in a newly
formed matrix of atelocollagen gel promotes restoration of the articular cartilage of the knee.
There were few transplant failures, except for detachment of the graft in one case.
http://dx.doi.org/10.1016/j.asmart.2016.07.127B0593
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Purpose: The quality of cartilage regeneration after marrow stimulation is well documented to
be unpredictable, because they do not regenerate consistent amount of cartilage. To overcome the
shortcomings of the subchondral drilling technique, various augmentation techniques using syn-
thetic collagen matrix, scaffolds or plug devices have been developed. However, their efficacy
remains unclear. The purpose of this prospective randomized controlled study is to evaluate
whether the subchondral drilling in combination with collagen gel augmentation could improve
the quality of cartilage regeneration in patients undergoing medial open wedge high tibial osteot-
omy (HTO) for the treatment of medial unicompartmental knee osteoarthritis (OA).
Methods: We randomized twenty-four patients undergoing HTO in combination with subchon-
dral drilling to receive either subchondral drilling alone (control group, n ¼ 12) or subchondral
drilling with collagen augmentation (experimental group, n¼12). At postoperative one year,
the clinical outcome in terms of Visual Analogue Scale of pain level (VAS), Knee Injury
and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee
(IKDC) score, and Tegner scores were evaluated. In addition, second look arthroscopic exami-
nation and biopsy of regenerated cartilage were carried out when the HTO plate was removed.
Biopsy specimens were graded by International Cartilage Repair Society Visual Assessment
Scale (ICRS II scores). Finally, radiologic outcome in terms of Magnetic Resonance Observa-
tion of Cartilage Repair Tissue (MOCART) scores was assessed using follow up MRI
undertaken.
Results: The clinical outcomes in terms of pain VAS, KOOS, IKDC and Tegner scores were sig-
nificantly improved in both groups without between-group differences (p > 0.1 in all compari-
sons). However, total ICRS II scores in the experimental group was higher than the control group
(1079 and 892, respectively) (p ¼ 0.005). Radiographic outcome basing on MOCART scores in
the experimental group were higher than the control group on postoperative one year follow-up
MRI (69 and 46, respectively) (p ¼ 0.001).
Discussion andConclusion: The quality of chondrogenesis following subchondral drilling with col-
lagen augmentation was superior to that of subchondral drilling only in patients undergoing HTO.
http://dx.doi.org/10.1016/j.asmart.2016.07.128B0594
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Background: Shoulder stiffness is common in the working population. Therapy can be conser-
vative (including anti-inflammatory drugs and physical therapy) or surgical. Arthroscopic capsu-
lar release has been reported to allow controlled and complete release of the contracted capsule
and to provide more immediate improvement than conservative therapy; however, treatment of
shoulder stiffness remains controversial. The purpose of this study was to compare the change in
shoulder range of motion (ROM) between nonsurgical treatment and arthroscopic capsular
release for shoulder stiffness.
Materials and Methods: We retrospectively reviewed our database and included patients with
shoulder stiffness treated between 2013 and 2015. The inclusion criteria for this study were (1)
a painful shoulder stiffness for at least one month; (2) restriction of passive external rotation of
at least 50% compared with the unaffected shoulder; (3) restriction of passive forward flexion
of less than 120; (4) pain at night causing a sleep disturbance and inability to lie on the
affected side; and (5) completion of more than 5 months of follow-up. The exclusion criteria
were (1) evidence of glenohumeral joint arthritis; (2) evidence of full-thickness rotator cuff
tear; (3) any fracture involving the shoulder girdle; and (4) previous surgery to the involved
shoulder. Our final study group included 34 patients with shoulder stiffness (17 males and
17 females. mean 62.8 years). Sixteen shoulders in 16 patients (8 males and 8 females,
mean 62.3 years) were treated nonsurgically (group N), and 18 shoulders in 18 patients (9
males and 9 females, mean 62.8 years) underwent arthroscopic capsular release (group A).
For group N, a physical therapy intervention was started after the medical examination. For
group A, 360 arthroscopic capsular release was performed under the general anesthesia fol-
lowing interscalene regional block. The day after the surgery, a physical therapy program
was started. Average follow-up duration of group N was 8.0 months and that of group A
was 8.3 months. Passive shoulder ROM was measured before initial treatment, at 1, 3, and
5 months after treatment, and at final follow-up. Maximum internal rotation was recorded as
the highest vertebral body that the patient was able to reach with the thumb of the affected
